JPH11502214A - イチョウの葉の乾操抽出物を含有する発泡性組成物 - Google Patents
イチョウの葉の乾操抽出物を含有する発泡性組成物Info
- Publication number
- JPH11502214A JPH11502214A JP8528064A JP52806496A JPH11502214A JP H11502214 A JPH11502214 A JP H11502214A JP 8528064 A JP8528064 A JP 8528064A JP 52806496 A JP52806496 A JP 52806496A JP H11502214 A JPH11502214 A JP H11502214A
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- foamable composition
- dry extract
- acid
- effervescent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 239000000284 extract Substances 0.000 title claims abstract description 22
- 235000008100 Ginkgo biloba Nutrition 0.000 title claims abstract description 13
- 235000011201 Ginkgo Nutrition 0.000 title abstract description 6
- 241000218628 Ginkgo Species 0.000 title abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- 239000002253 acid Substances 0.000 claims description 13
- 239000000796 flavoring agent Substances 0.000 claims description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 9
- 244000194101 Ginkgo biloba Species 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 5
- 150000007513 acids Chemical class 0.000 claims description 5
- 235000013355 food flavoring agent Nutrition 0.000 claims description 5
- 239000003765 sweetening agent Substances 0.000 claims description 5
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 4
- 229920000136 polysorbate Polymers 0.000 claims description 4
- 159000000000 sodium salts Chemical class 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011975 tartaric acid Substances 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 2
- 150000001218 Thorium Chemical class 0.000 claims description 2
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 229950008882 polysorbate Drugs 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 16
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 239000003826 tablet Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- -1 flavone glycosides Chemical class 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 4
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical class OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 235000021092 sugar substitutes Nutrition 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229930184727 ginkgolide Natural products 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229960003511 macrogol Drugs 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- FUWVMBCPMRAWPG-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-hydroxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)OCC(O)CO FUWVMBCPMRAWPG-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031104 Arterial Occlusive disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 206010067371 Menopausal depression Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 208000021328 arterial occlusion Diseases 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229940106580 ginkgo biloba leaf extract Drugs 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 208000021156 intermittent vascular claudication Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 1
- 235000018342 monosodium citrate Nutrition 0.000 description 1
- 239000002524 monosodium citrate Substances 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.イチョウの葉の乾燥抽出物および生理学的に許容される酸またはそれらのナ トリウム塩、および生理学的に許容される炭酸塩または炭酸水素塩を、水を加え た後できる溶液がpH値約6から8で、少なくとも1時間は安定であるような割 合の発泡性混合物を含有する発泡性組成物。 2.酸および炭酸塩または炭酸水素塩の重量比が約1:1から1:3であることを 特徴とする、請求項1に記載の発泡性組成物。 3.酸がクエン酸または酒石酸またはそれらの一ナトリウム塩であることを特徴 とする、請求項1に記載の発泡性組成物。 4.炭酸塩または炭酸水素塩がナトリウム塩であることを特徴とする、請求項1 に記載の発泡性組成物。 5.生理学的に許容される水溶性界面活性剤の添加含有を特徴とする、請求項1 に記載の発泡性組成物。 6.界面活性剤がポリソルベートまたはナトリウムジオクチルスルホサクシネー トであることを特徴とする、請求項5に記載の発泡性組成物。 7.甘味剤の添加含有を特徴とする、請求項1に記載の発泡性組成物。 8.香味剤の添加含有を特徴とする、請求項1に記載の発泡性組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19509856A DE19509856C2 (de) | 1995-03-17 | 1995-03-17 | Verwendung einer Brausezusammensetzung mit Ginkgo-Biloba Trockenextrakt zur Behandlung peripherer und cerebraler Durchblutungsstörungen |
DE19509856.0 | 1995-03-17 | ||
PCT/EP1996/001135 WO1996029085A1 (de) | 1995-03-17 | 1996-03-15 | Brausezusammensetzung mit ginkgo-biloba trockenextrakt |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11502214A true JPH11502214A (ja) | 1999-02-23 |
JP3935934B2 JP3935934B2 (ja) | 2007-06-27 |
Family
ID=7757035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52806496A Expired - Fee Related JP3935934B2 (ja) | 1995-03-17 | 1996-03-15 | イチョウの葉の乾操抽出物を含有する発泡性飲食用組成物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US6399099B1 (ja) |
EP (1) | EP0814824B1 (ja) |
JP (1) | JP3935934B2 (ja) |
AT (1) | ATE200982T1 (ja) |
DE (2) | DE19509856C2 (ja) |
DK (1) | DK0814824T3 (ja) |
ES (1) | ES2157429T3 (ja) |
WO (1) | WO1996029085A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003503324A (ja) * | 1999-06-29 | 2003-01-28 | イクセル・ハーバシューティカルズ | 発泡性緑茶抽出物製剤 |
JP6429348B1 (ja) * | 2017-07-03 | 2018-11-28 | 株式会社ビー・エッチ | 発泡性緑葉粉末 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59706616D1 (de) † | 1997-10-27 | 2002-04-18 | Gergely Gerhard | Brausezubereitung mit Pflanzenextrakt |
US5948439A (en) * | 1997-10-31 | 1999-09-07 | Farmo-Nat Ltd. | Effervescent granules |
EP0919227A1 (de) * | 1997-12-01 | 1999-06-02 | Gerhard Dr. Gergely | Brausezubereitung enthaltend ein Pflanzenextrakt |
EP0922450B1 (de) * | 1997-12-01 | 2003-04-23 | Dr. Gergely & Co. | Brausezubereitung enthaltend ein Pflanzenextrakt |
DE102005062417A1 (de) * | 2005-12-27 | 2007-08-23 | Korth, Ruth-Maria, Dr.med. | Kompositionen mit spezifischen und unspezifischen Lipidantagonisten |
US11039997B2 (en) | 2005-12-27 | 2021-06-22 | Ruth-Maria Korth | Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound |
ITMI20071492A1 (it) * | 2007-07-24 | 2009-01-25 | S I I T Srl Servizio Internazi | "composizioni per il trattamento e la prevenzione di condizioni di vertigine e acufeni comprendenti citicolina, estratto di ginkgo biloba e flavoni dimerici di ginkgo biloba" |
EP3263113A1 (de) * | 2016-06-30 | 2018-01-03 | Jürgen Mertin | Anwendung und präparat (enthaltend colecalciferol, omega-3-fettsäure and ginkgo biloba) zur aufrechterhaltung und verbesserung kognitiver funktionen |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH667590A5 (it) * | 1986-07-24 | 1988-10-31 | Inpharzam Int Sa | Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. . |
GB8624628D0 (en) * | 1986-10-14 | 1986-11-19 | Scras | Soluble/splitable tablets |
DE3832277A1 (de) * | 1988-09-22 | 1990-03-29 | Guenter Stephan | Brausetablette |
DE3940092A1 (de) * | 1989-12-04 | 1991-06-06 | Schwabe Willmar Gmbh & Co | Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel |
JPH0769862A (ja) * | 1993-09-01 | 1995-03-14 | Kao Corp | 入浴剤組成物 |
-
1995
- 1995-03-17 DE DE19509856A patent/DE19509856C2/de not_active Expired - Fee Related
-
1996
- 1996-03-15 ES ES96907489T patent/ES2157429T3/es not_active Expired - Lifetime
- 1996-03-15 AT AT96907489T patent/ATE200982T1/de active
- 1996-03-15 DE DE59606882T patent/DE59606882D1/de not_active Expired - Lifetime
- 1996-03-15 US US08/913,896 patent/US6399099B1/en not_active Expired - Fee Related
- 1996-03-15 JP JP52806496A patent/JP3935934B2/ja not_active Expired - Fee Related
- 1996-03-15 EP EP96907489A patent/EP0814824B1/de not_active Expired - Lifetime
- 1996-03-15 WO PCT/EP1996/001135 patent/WO1996029085A1/de active IP Right Grant
- 1996-03-15 DK DK96907489T patent/DK0814824T3/da active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003503324A (ja) * | 1999-06-29 | 2003-01-28 | イクセル・ハーバシューティカルズ | 発泡性緑茶抽出物製剤 |
JP6429348B1 (ja) * | 2017-07-03 | 2018-11-28 | 株式会社ビー・エッチ | 発泡性緑葉粉末 |
JP2019013219A (ja) * | 2017-07-03 | 2019-01-31 | 株式会社ビー・エッチ | 発泡性緑葉粉末 |
Also Published As
Publication number | Publication date |
---|---|
WO1996029085A1 (de) | 1996-09-26 |
DE19509856C2 (de) | 1997-09-11 |
US6399099B1 (en) | 2002-06-04 |
JP3935934B2 (ja) | 2007-06-27 |
EP0814824B1 (de) | 2001-05-09 |
DE19509856A1 (de) | 1996-09-19 |
ATE200982T1 (de) | 2001-05-15 |
ES2157429T3 (es) | 2001-08-16 |
DE59606882D1 (de) | 2001-06-13 |
DK0814824T3 (da) | 2001-06-25 |
EP0814824A1 (de) | 1998-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4801255B2 (ja) | 沸騰性酸−塩基対を含有する製薬学的組成物 | |
RU2216318C2 (ru) | Твердая быстроразрушающаяся шипучая композиция цетиризина для перорального введения | |
JP5090918B2 (ja) | 経口用分散性医薬組成物 | |
JPH0786086B2 (ja) | 薬剤組成物 | |
KR101203186B1 (ko) | 약물의 맛이 차폐된 경구용 약학 조성물 및 그 제조 방법 | |
JP3935934B2 (ja) | イチョウの葉の乾操抽出物を含有する発泡性飲食用組成物 | |
US5728401A (en) | Effervescent ranitidine formulations | |
KR20150002453A (ko) | 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제 | |
JPH04327526A (ja) | 経口用固形製剤 | |
JP4814636B2 (ja) | ビグアナイド系薬物の内服製剤 | |
KR101175120B1 (ko) | 나테글리니드 함유 제제 | |
DE10038364A1 (de) | Pharmazeutische, Ramipril enthaltende Brauseformulierung | |
JPH09502709A (ja) | エストロン誘導体及びカルシウム塩含有の経口、水溶性製薬組成物 | |
AU777234B2 (en) | Pharmaceutical effervescent formulation containing metamizol | |
KR100435514B1 (ko) | 실데나필 젖산염의 속효제형 | |
JP2005047897A (ja) | 臭気除去方法 | |
EP1757274B1 (de) | Brausezubereitung gegen Erkältungssymptome | |
JP2005272401A (ja) | チュアブル錠 | |
RU2160601C1 (ru) | Растворимая шипучая лекарственная композиция с растительным экстрактом | |
JP2000273038A (ja) | 口腔内溶解性錠剤 | |
RU2276982C2 (ru) | Средство, обладающее противовоспалительным, анальгетическим, жаропонижающим действием в форме таблетки | |
RU2155033C1 (ru) | Растворимая шипучая лекарственная композиция | |
JPH0564126B2 (ja) | ||
TR2021001998A2 (tr) | Pelargoni̇um türleri̇ni̇ i̇çeren bi̇r efervesan bi̇leşi̇m | |
MXPA01008150A (en) | Pharmaceutical effervescent formulation containing metamizol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061024 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070124 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070313 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070322 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110330 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110330 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120330 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130330 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130330 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140330 Year of fee payment: 7 |
|
LAPS | Cancellation because of no payment of annual fees |